Immuno-Biological Laboratories Co., Ltd. Financial Overview
Immuno-Biological Laboratories Co., Ltd.'s market cap is currently ¥15.32B. The company's EPS TTM is ¥8.67; its P/E ratio is 48.00; Immuno-Biological Laboratories Co., Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
